AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
The Development of a Rhizoma Chuanxiong Product Using a Proprietary Pharmaceutical Platform Technology
Summary
The present invention employs a proprietary pharmaceutical technology to estimate the composition of human dosage for the treatment or prevention of angina using an extract of Rhizoma chuanxiong. These extracts exhibit synergistic effects in inducing vasodilatory effects, preventing platelet aggregation, and inducing anti-thrombotic effects. Such extracts can be developed as cardiovascular events, such infarction, cardiac ischemia, a treatment/prevention of various as unstable angina, myocardial heart failure, and stroke.
Application No.
08/MED/301
Others
Inventor(s): Professor Ge LIN, Department of Pharmacology
Country/Region
Hong Kong
For more information, please click Here
